Inadequate and delayed characterization of cutaneous reactions for US Food and Drug Administration-approved oncologic drugs from 2011-2020 leading to medication discontinuation
J Am Acad Dermatol. 2021 Nov;85(5):1351-1352.
doi: 10.1016/j.jaad.2020.10.047.
Epub 2020 Oct 23.
1 Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: [email protected].
2 Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
3 Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
4 Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO.